The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of daratumumab with weekly carfilzomib, pomalidomide, and dexamethasone in relapsed and refractory multiple myeloma.
 
Andrew J Yee
Honoraria - Amgen; Celgene
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Karyopharm Therapeutics; Oncopeptides; Regeneron; Sanofi
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen (Inst); Takeda (Inst)
 
Omar Nadeem
Consulting or Advisory Role - Adaptive Biotechnologies; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; GPCR Therapeutics; Janssen; Karyopharm Therapeutics; Takeda
Research Funding - Janssen (Inst); Takeda (Inst)
 
Jacalyn Rosenblatt
Employment - Bioclinica; Imaging Endpoints; Parexel; Wolters Kluwer (I)
Honoraria - Bristol-Myers Squibb; Merck
Consulting or Advisory Role - Amgen; Attivare Therapeutics; BMS; Celgene; Karyopharm Therapeutics; Kite/Gilead; Partner Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Sanofi (Inst)
Other Relationship - Dava Oncology
 
Giada Bianchi
Consulting or Advisory Role - Karyopharm Therapeutics
 
Elizabeth O'Donnell
Consulting or Advisory Role - BMS; Celgene; Janssen; Karyopharm Therapeutics; Oncopeptides; Sanofi; Takeda
Research Funding - Amgen (Inst); Janssen (Inst); Sanofi (Inst); Takeda (Inst)
 
Andrew R. Branagan
Consulting or Advisory Role - Adaptive Biotechnologies; BeiGene; CSL Behring; Genzyme; Karyopharm Therapeutics; Pharmacyclics/Janssen
 
Cynthia C. Harrington
No Relationships to Disclose
 
Emerentia A. Agyemang
No Relationships to Disclose
 
Marilyn T. Gammon
No Relationships to Disclose
 
Kathleen J. Lively
No Relationships to Disclose
 
Lisette A. Packer
No Relationships to Disclose
 
Zachary S. Bernstein
No Relationships to Disclose
 
Rebecca T. Lyons
No Relationships to Disclose
 
Manal Riadi
No Relationships to Disclose
 
Sean M. Rowell
No Relationships to Disclose
 
Cailin McVey
No Relationships to Disclose
 
Amy C. Goguen
No Relationships to Disclose
 
Nora K. Horick
Employment - Northwest Biotherapeutics (I)
Stock and Other Ownership Interests - Northwest Biotherapeutics (I)
Patents, Royalties, Other Intellectual Property - An immediate family member holds patents, has patents pending, and receives royalties from a technology relating to health or medicine. (I)
 
Paul G. Richardson
Consulting or Advisory Role - Celgene; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Oncopeptides; Sanofi; Secura Bio; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Oncopeptides (Inst); Takeda (Inst)
 
Noopur S. Raje
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Caribou Biosciences; Celgene; Immuneel Therapeutics; Janssen Oncology; Merck; Pfizer; Takeda
Research Funding - Bluebird Bio (Inst)